About 3% of all melanomas are of ocular origin; of these, 85% are uveal. Uveal melanomas are rare, with standardized incidence rates ranging from approximately 2 to 8 cases per 1 million people in the United States and Europe. The typical presentation of uveal melanoma depends on the site of origin: choroid, iris, or ciliary body. About 80-90% of all uveal melanomas develop in the posterior choroid. Uveal melanoma is typically a clinical rather than a pathologic diagnosis. Currently, several options are available for the management of uveal melanoma, including observation, transpupillary thermotherapy, brachytherapy, stereotactic radiotherapy, proton radiotherapy, and tumor resection.
CITATION STYLE
Ludwig, M., Garden, A. S., Williams, M. D., & Gombos, D. S. (2010). Management of Uveal Melanoma. In Ophthalmic Oncology (pp. 201–213). Springer US. https://doi.org/10.1007/978-1-4419-0374-7_15
Mendeley helps you to discover research relevant for your work.